JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB133335

Anti-CD14 antibody [EPR3653]

  • BOND RX™ Validated
  • 20ul selling size
  • RabMAb
  • Recombinant
  • What is this?

4

(1 Review)

|

(36 Publications)

Anti-CD14 antibody [EPR3653] (ab133335) is a rabbit monoclonal antibody detecting CD14 in Western Blot, IHC-P. Suitable for Human.

- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications

View Alternative Names

CD14, Monocyte differentiation antigen CD14, My23 antigen, Myeloid cell-specific leucine-rich glycoprotein

10 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD14 antibody [EPR3653] (AB133335)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD14 antibody [EPR3653] (AB133335)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human colon tissue sections labeling CD14 with purified ab133335 at 1/2000 dilution (0.04 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD14 antibody [EPR3653] (AB133335)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD14 antibody [EPR3653] (AB133335)

Immunohistochemical analysis of Formalin-fixed, paraffin- embedded Human tonsil tissue labelling CD14 with ab133335 (unpurified) at 1/500 dilution. Heat mediated antigen retrieval was performed before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD14 antibody [EPR3653] (AB133335)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD14 antibody [EPR3653] (AB133335)

Tissue Microarrays stained for "Anti-CD14 antibody [EPR3653]" using "ab133335"in immunohistochemical analysis. This table provides a detailed overview of positive (tick mark) and negative (cross mark) staining per sample type tested. The sections were pre-treated using Heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0) for 20 minutes. The sections were incubated with ab133335 for 30 mins at room temperature followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD14 antibody [EPR3653] (AB133335)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD14 antibody [EPR3653] (AB133335)

Immunohistochemical analysis of Formalin-fixed, paraffin- embedded Human placenta tissue labelling CD14 with ab133335 (unpurified) at 1/500 dilution. Heat mediated antigen retrieval was performed before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD14 antibody [EPR3653] (AB133335)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD14 antibody [EPR3653] (AB133335)

Immunohistochemical analysis of Formalin-fixed, paraffin- embedded human tonsil tissue labelling CD14 with ab133335 (unpurified) at 1/500 dilution. No blocking step performed. Anti-Rabbit HRP polymer was used as the secondary detection system. Heat-mediated antigen retrieval was performed using EDTA based pH 9.0 buffer.

Western blot - Anti-CD14 antibody [EPR3653] (AB133335)
  • WB

Lab

Western blot - Anti-CD14 antibody [EPR3653] (AB133335)

Blocking/Diluting buffer and concentration : 5% NFDM/TBST

All lanes:

Western blot - Anti-CD14 antibody [EPR3653] (ab133335) at 1/1000 dilution

Lane 1:

Human tonsil lysates prepared in RIPA lysis method at 20 µg

Lane 2:

Human tonsil lysates prepared in 1%SDS Hot lysis method at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 40 kDa

false

Exposure time: 45s

Western blot - Anti-CD14 antibody [EPR3653] (AB133335)
  • WB

Lab

Western blot - Anti-CD14 antibody [EPR3653] (AB133335)

Blocking and diluting buffer : 5% NFDM/TBST

The expression level in HeLa and U-937 are low (PMID : 9886426 and 15730927)

All lanes:

Western blot - Anti-CD14 antibody [EPR3653] (ab133335) at 1/1000 dilution

Lane 1:

Human tonsil tissue lysate prepared in 1% SDS Hot lysis method at 20 µg

Lane 2:

HeLa (Human cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 3:

U-937 (Human histiocytic lymphoma) whole cell lysate at 20 µg

Secondary

Lane 1:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Lanes 2 - 3:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 40 kDa

Observed band size: 53 kDa

false

Exposure time: 3min

Western blot - Anti-CD14 antibody [EPR3653] (AB133335)
  • WB

Unknown

Western blot - Anti-CD14 antibody [EPR3653] (AB133335)

All lanes:

Western blot - Anti-CD14 antibody [EPR3653] (ab133335) at 1/1000 dilution

Lane 1:

PBMC cell lysate prepared in 1% SDS Hot lysis method at 10 µg

Lane 2:

Human tonsil tissue lysate prepared in 1%SDS Hot lysis method at 10 µg

Lane 3:

SW480 cell lysate prepared in 1%SDS Hot lysis method at 10 µg

Secondary

All lanes:

Goat Anti-rabbit HRP at 1/2000 dilution

Predicted band size: 40 kDa

Observed band size: 53 kDa

false

Western blot - Anti-CD14 antibody [EPR3653] (AB133335)
  • WB

Lab

Western blot - Anti-CD14 antibody [EPR3653] (AB133335)

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-CD14 antibody [EPR3653] (ab133335) at 1/1000 dilution

All lanes:

His-Tagged Human CD14 (aa20 to 345) recombinant protein at 0.015 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 40 kDa

Observed band size: 43 kDa

false

Exposure time: 1s

OI-RD Scanning - Anti-CD14 antibody [EPR3653] (AB133335)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-CD14 antibody [EPR3653] (AB133335)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

  • HRP

    HRP Anti-CD14 antibody [EPR3653]

  • Carrier free

    Anti-CD14 antibody [EPR3653] - BSA and Azide free

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-CD14 antibody [EPR3653]

  • Carrier free

    Anti-CD14 antibody [EPR3653] - Low endotoxin, Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR3653

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/2000", "IHCP-species-notes": "<p><strong>For unpurified use at 1/500 - 1/1000.</strong></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

Product Specifications
Anti-CD14 antibody [EPR3653] (ab133335) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-P, WB in human samples.
Anti-CD14 antibody [EPR3653] (ab133335) specifically detects CD14 (UniProt ID: P08571; Molecular weight: 37kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).

Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-CD14 antibody [EPR3653] (ab133335) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-CD14 antibody [EPR3653] (ab133335) has been cited over 27 times in peer reviewed journals and is trusted by the scientific community.


Related Products
Antibody clone EPR3653 is also available pre-conjugated to a variety of labels for your convenience - HRP, Alexa Fluor® 594 (ab195525, ab314340).

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Coreceptor for bacterial lipopolysaccharide (PubMed : 1698311, PubMed : 23264655). In concert with LBP, binds to monomeric lipopolysaccharide and delivers it to the LY96/TLR4 complex, thereby mediating the innate immune response to bacterial lipopolysaccharide (LPS) (PubMed : 20133493, PubMed : 22265692, PubMed : 23264655). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed : 8612135). Acts as a coreceptor for TLR2 : TLR6 heterodimer in response to diacylated lipopeptides and for TLR2 : TLR1 heterodimer in response to triacylated lipopeptides, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway (PubMed : 16880211). Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-) (PubMed : 23880187).
See full target information CD14

Publications (36)

Recent publications for all applications. Explore the full list and refine your search

BMC cancer 25:763 PubMed40269765

2025

Pretreatment plasma sCD14 as a prognostic indicator in advanced non-small cell lung cancer patients undergoing immunotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Liyuan Dai,Liling Huang,Lin Li,Le Tang,Jiarui Yao,Yuankai Shi,Xiaohong Han

Cell reports. Medicine 5:101851 PubMed39657667

2024

Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders.

Applications

Unspecified application

Species

Unspecified reactive species

Jiaying Toh,Andrea J Reitsma,Tetsuya Tajima,Sheren F Younes,Chimere Ezeiruaku,Kayla C Jenkins,Josselyn K Peña,Shuchun Zhao,Xi Wang,Esmond Y Z Lee,Marla C Glass,Laurynas Kalesinskas,Ananthakrishnan Ganesan,Irene Liang,Joy A Pai,James T Harden,Francesco Vallania,Edward A Vizcarra,Govind Bhagat,Fiona E Craig,Steven H Swerdlow,Julie Morscio,Daan Dierickx,Thomas Tousseyn,Ansuman T Satpathy,Sheri M Krams,Yasodha Natkunam,Purvesh Khatri,Olivia M Martinez

Scientific reports 14:28055 PubMed39543171

2024

Platelet activation through CD62P and the formation of platelet-monocyte complexes are associated with the exacerbation of mucosal inflammation in patients with ulcerative colitis.

Applications

Unspecified application

Species

Unspecified reactive species

Yasuki Sano,Takashi Tomiyama,Naoto Yagi,Yuka Ito,Yusuke Honzawa,Tomomitsu Tahara,Tsukasa Ikeura,Toshiro Fukui,Shinji Shimoda,Makoto Naganuma

Nature neuroscience 27:2354-2365 PubMed39501036

2024

Cell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesions.

Applications

Unspecified application

Species

Unspecified reactive species

Celia Lerma-Martin,Pau Badia-I-Mompel,Ricardo O Ramirez Flores,Patricia Sekol,Philipp S L Schäfer,Christian J Riedl,Annika Hofmann,Thomas Thäwel,Florian Wünnemann,Miguel A Ibarra-Arellano,Tim Trobisch,Philipp Eisele,Denis Schapiro,Maximilian Haeussler,Simon Hametner,Julio Saez-Rodriguez,Lucas Schirmer

Journal for immunotherapy of cancer 12: PubMed39366751

2024

PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF-caspase 8-GSDMD/E axis in ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yu Xia,Pu Huang,Yi-Yu Qian,Zanhong Wang,Ning Jin,Xin Li,Wen Pan,Si-Yuan Wang,Ping Jin,Emmanuel Kwateng Drokow,Xiong Li,Qi Zhang,Zhengmao Zhang,Pingfei Li,Yong Fang,Xiang-Ping Yang,Zhiqiang Han,Qing-Lei Gao

Gastroenterology report 12:goae055 PubMed38818308

2024

Integrated analysis of colorectal cancer metastasis identifies characteristics of tumor cell during metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Haoyu Fu,Xiaohuan Lu,Tiantian Ji,Liping Wang,Guobin Wang,Lin Wang,Zheng Wang

Cell reports. Medicine 5:101415 PubMed38382467

2024

Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Shun Wang,Le Zhu,Tianen Li,Xinxin Lin,Yan Zheng,Da Xu,Yu Guo,Ze Zhang,Yan Fu,Hao Wang,Xufeng Wang,Tiantian Zou,Xiaotian Shen,Lumin Zhang,Nannan Lai,Lu Lu,Lunxiu Qin,Qiongzhu Dong

Cancer immunology, immunotherapy : CII 72:4385-4397 PubMed37938368

2023

Spatial immune composition of tumor microenvironment in patients with pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Eline S Zwart,Thomas van Ee,Alsya J Affandi,Lenka N C Boyd,Ernesto Rodriguez,Joke M M den Haan,Arantza Farina,Nicole C T van Grieken,Laura L Meijer,Yvette van Kooyk,Reina E Mebius,Geert Kazemier

Journal of cancer research and clinical oncology 149:14731-14743 PubMed37587309

2023

The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Eline S Zwart,Thomas van Ee,Deesje Doppenberg,Arantza Farina,Johanna W Wilmink,Eva Versteijne,Olivier R Busch,Marc G Besselink,Laura L Meijer,Yvette van Kooyk,Reina E Mebius,Geert Kazemier

Cell reports 42:112525 PubMed37243592

2023

Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease.

Applications

Unspecified application

Species

Unspecified reactive species

Theodore S Kapellos,Kevin Baßler,Wataru Fujii,Christina Nalkurthi,Anna C Schaar,Lorenzo Bonaguro,Tal Pecht,Izabela Galvao,Shobhit Agrawal,Adem Saglam,Erica Dudkin,Amit Frishberg,Elena de Domenico,Arik Horne,Chantal Donovan,Richard Y Kim,David Gallego-Ortega,Tessa E Gillett,Meshal Ansari,Jonas Schulte-Schrepping,Nina Offermann,Ignazio Antignano,Burcu Sivri,Wenying Lu,Mathew S Eapen,Martina van Uelft,Collins Osei-Sarpong,Maarten van den Berge,Hylke C Donker,Harry J M Groen,Sukhwinder S Sohal,Johanna Klein,Tina Schreiber,Andreas Feißt,Ali Önder Yildirim,Herbert B Schiller,Martijn C Nawijn,Matthias Becker,Kristian Händler,Marc Beyer,Melania Capasso,Thomas Ulas,Jan Hasenauer,Carmen Pizarro,Fabian J Theis,Philip M Hansbro,Dirk Skowasch,Joachim L Schultze
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com